CAS RN: 1137606-74-6
2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, coMpd. with N-cyclohexylcyclohexanaMine (1:1)
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1137606-74-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1137606-74-6 / N-cyclohexylcyclohexanamine;5-fluoro-2-oxo-1H-pyrazine-3-carbonitrile
6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile compound with dicyclohexylamine (1:1) | N-cyclohexylcyclohexanamine;5-fluoro-2-oxo-1H-pyrazine-3-carbonitrile | Favipiravir N-1 Int.
Standard CAS: 1137606-74-6
Multi CAS: Yes
Basic Information
copy
CAS
1137606-74-6 copy
Multi CAS
Yes copy
Molecular Formula
C17H25FN4O copy
Molecular Weight
320.400000 copy
Exact Mass
320.201240 copy
SMILES
C1CCC(CC1)NC2CCCCC2.C1=C(N=C(C(=O)N1)C#N)F copy
InChI
InChI=1S/C12H23N.C5H2FN3O/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12;6-4-2-8-5(10)3(1-7)9-4/h11-13H,1-10H2;2H,(H,8,10) copy
InChIKey
CUEAMQKUSNCUDI-UHFFFAOYSA-N copy
Synonyms
6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile compound with dicyclohexylamine (1:1)
N-cyclohexylcyclohexanamine;5-fluoro-2-oxo-1H-pyrazine-3-carbonitrile
Favipiravir N-1 Int.
C17H25FN4O
SCHEMBL28456157 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
23 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.71 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
86.41 copy
TPSA
81.57 copy
LogP / Solubility
WLOGP
3.02 copy
MLOGP
2.67 copy
XLogP3
3.02 copy
Consensus LogP
2.9 copy
Log S (ESOL)
-3.79 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.37 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.49 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.53 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2.5 copy